Alternatives to CurifyLabs

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered breast cancer detection and risk assessment solutions.

Patient-controlled health data platform for record consolidation and research sharing.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

AI-powered research assistant for scientific literature review and data extraction.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

AI company using federated learning to solve biological complexity and accelerate drug discovery.

Telehealth platform offering personalized treatment plans for weight care, wellness, skin, hair, mental health, and more.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing oral small molecule medicines for immunological and chronic diseases.

Personalised nutrition brand using AI-driven technology and 3D printing.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Developing highly targeted, small molecule medicines.

Advancing next-generation mRNA medicines.

AI-powered antibody discovery platform.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Digital pathology imaging technology and AI-driven precision pathology software.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Developing a new class of anti-IgE therapy for multiple atopic conditions.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Developing first-in-class oral therapy for BK polyomavirus infections.

AI platform for engineering molecular glues to create a new class of medicines.

Global life sciences company providing diagnostic and biopharma laboratory services.

Immunotherapy company targeting oncology and autoimmune diseases.

A biotechnology company focused on oncology drug discovery.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.

Developing novel male contraceptives.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Scalable, one-time curative in-vivo gene editing therapies.

Advancing targeted alpha therapies.

A biopharmaceutical company focused on drug discovery and development.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Biotechnology company developing novel therapeutics by harnessing the autophagy pathway to treat serious diseases.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Biopharmaceutical company developing T-cell therapies for solid tumor cancers.